---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014905"
form_type: "8-K"
ticker: "KAPA"
cik: "0001962011"
company_name: "Kairos Pharma, LTD."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T11:28:08.971769+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Kairos Pharma shareholders approve dilutive stock issuance, elect directors, enter IR pact

## Summary
- Entered one-year IR services agreement with Barretto Pacific Corp for $170,000 fee.
- Shareholders elected all four director nominees (Yu, Bae, Keyoung, Sighvi).
- Ratified Weinberg & Company as independent auditor for FY2025.
- Approved issuance of >20% common stock at price below NYSE American minimum price.
- Advisory votes approved executive compensation and 1-year frequency.

## SEC filing metadata
- accession: 0001641172-25-014905
- form_type: 8-K
- ticker: KAPA
- cik: 0001962011
- company_name: Kairos Pharma, LTD.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1962011/000164117225014905/0001641172-25-014905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1962011/000164117225014905/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014905
- JSON: https://secwatch.observer/filing/0001641172-25-014905.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014905.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.